![]() ![]() The organisation grew from 100 people at a single site in Galway to over 1,250 people across a global network of four sites in Ireland, the USA and Singapore. The expansion included three company acquisitions, a strategic joint venture in Asia, and the raising of significant debt and equity financing. During Helen’s time as CEO, the company grew five-fold to become the largest indigenous medical device company. The company is currently ranked among the world’s top 10 medical device outsource providers. Creganna-Tactx Medical is a global supplier to the medical device industry specialising in products, technologies and solutions for minimally invasive therapies. Helen Ryan was the Chief Executive Officer of Creganna-Tactx Medical from 2005 until September 2013. Helen was listed as one of the Top 100 Women in STEM in Ireland. Electronic Engineering Degree from UCD and was then awarded her PhD from The University of Edinburgh in the area of AI based conversational agents and multimodal interfaces. Helen also held the position of Sales Director at Celtrak Ltd (acquired by Thermo King, 2015). Prior to joining Atlantic Bridge, Helen was a member of the NDRC Investment Committee playing a key role in the allocation of €45m capital into new technology ventures with a particular focus health and ICT. Active in the early stage ecosystem Helen is also a board member to several companies and a mentor and advisor to organisations including Knowledge Transfer Ireland, UCD VentureLaunch, NDRC, TechIreland and TechInnovate. Helen is a Kauffman Fellow (Class 22, 2019) and in 2021 was nominated as VP of TechTour Deep Tech (Software). Having successfully sourced and financed dozens of IP rich technology ventures in software (enterprise, cloud, mobile), hardware (robotics, semiconductors) and life-sciences (medtech, diagnostics), Helen brings over 15 years’ experience in early stage investing. At Atlantic Bridge, Helen manages early stage investing and leads investments from University Fund I & II which are focused on early stage deeptech companies built from world class research generated at leading research institutions and universities. Helen joined Atlantic Bridge in 2015 on our University Bridge Fund. He is a Kauffman Fellow having completed the program in Palo Alto, California as a member of Class 17 in 2014.Īn avid outdoor enthusiast, Paul participates in many outdoor acivites such as hiking and orienteering and volunteers as a Mountain Ranger in the Dublin Mountains. Paul holds a First Class Honours degree in Electronic Engineering from University College Dublin and a Masters in Management from the Smurfit Business School, University College Dublin and is the holder of a number of US patents. Paul was also a key member of Chipsensors, an Irish fabless start-up developing environmental sensing devices, which was acquired by Silicon Laboratories in 2010. At Analog Devices he led the development of fiber-optic communications products. He worked for global companies as well as start-ups, including Analog Devices, Parthus, and Phyworks. Prior to Atlantic Bridge, Paul spent 11 years in various engineering and management roles in the semiconductor industry. Paul joined Atlantic Bridge in 2012 and brings over 14 years’ operational experience in the Semiconductor industry. He also serves on the boards of the Association of Asian American Investment Managers (AAAIM) and the Bullis-Purissima Elementary School Foundation.ĭavid holds a BS and an MA from Stanford University, and an MBA from the MIT Sloan School of Management where he was recipient of the Merit Scholarship and Patrick McGovern Award. David began his career as an investment banker at Robertson Stephens & Company.ĭavid is a board member, past president and past chairman of the Asia America MultiTechnology Association (AAMA), which is the oldest and largest pan-Asian, cross-border technology executive network in Silicon Valley. ![]() He also held various operating roles at CIENA Corporation, ONI Systems, Cisco Systems and Proxim. Prior to that, David was Vice President at The Carlyle Group, a global private equity firm, after serving as head of business development for a Carlyle portfolio company. David was previously Managing Director for WI Harper, a cross-border venture capital firm. Prior to Atlantic Bridge, David was Managing Director of WestSummit Capital where he served as its representative on the boards of Twitch (acquired by Amazon), Mirantis and Maginatics (acquired by EMC) among others. He previously represented the firm on the boards of Movidius (acquired by Intel), Decawave (acquired by Qorvo) and Navitas (Nasdaq IPO), among others. He led the firm’s investments and represents Atlantic Bridge on the boards of Semsysco, SweGaN, Caption Health, Syntiant and AtScale. David Lam is General Partner of Atlantic Bridge Capital. ![]()
0 Comments
Leave a Reply. |